Matches in Nanopublications for { ?s ?p "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344388.RAdNTmVMPACRUwgrLM75it66d8OUuNY5bEvypdau78GQQ130_provenance.
- assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP645137.RAX8C55HwY5UzYCkCZpvuwWQg6Qj7QE8HQ70xaPxd8-HM130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645137.RAX8C55HwY5UzYCkCZpvuwWQg6Qj7QE8HQ70xaPxd8-HM130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP645138.RA7rwEZGSnz8pxN-nWO9slRloBhzPsVUrU4ZxyxxE40YM130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645138.RA7rwEZGSnz8pxN-nWO9slRloBhzPsVUrU4ZxyxxE40YM130_provenance.